Abstract
This study describes the development and evaluation of stability-indicating liquid chromatographic (LC) and UV spectrophotometric methods for the quantification of ciprofibrate (CPF) in tablets and capsules. Isocratic LC separation was achieved on a RP18 column using a mobile phase of o-phosphoric acid (0.1% v/v), adjusted to pH 3.0 with triethylamine (10% v/v) and acetonitrile (35:65 v/v), with a flow rate of 1.0 mL min-1. Detection was achieved with a photodiode array detector at 233 nm. For the spectrophotometric analysis, ethanol and water were used as the solvent and a wavelength of 233 nm was selected for the detection. The methods were validated according to International Conference on Harmonization (ICH) guidelines for validating analytical procedures. Statistical analysis showed no significant difference between the results obtained by the two methods. The proposed methods were successfully applied to the CPF quality-control analysis of tablets and capsules.
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference17 articles.
1. Stability indicating HPLC and spectrophotometric methods for the determination of bupropion hydrochloride in the presence of its alkaline degradates and related impurity;ABBAS S. S.;Bull. Fac. Pharm, Cairo Univ.,2012
2. Development of validated stability-indicating assay methods - critical review;BAKSHI M.;J. Pharm. Biomed.,2002
3. Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver;BIGHETTI E. J. B.;Lipids Health Dis.,2009
4. Ciprofibrate diminishes NON-HDLc and improves HDLc in patients with Frederickson type IV dyslipidemia phenotype;BERMÚDEZ-PIRELA V.;AVFT,2005
5. Stability-indicating derivative spectrophotometry method for the determination of biapenem in the presence of its degradation products;CIELECKA-PIONTEK J.;Cent. Eur. J. Chem,2011
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献